🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Another PD-1 x VEGF deal, this time from $PFE. Jacob Plieth mentioned SSGJ-707 in a story last year about similarly acting assets up for licensing oncologypipeline.com/apexonco/lanov…

$RHHBY PR on yesterday's Columvi / Starglo adcom is hilarious. Basically says the issue of US applicability was discussed, but somehow omits to say the vote was 8-1 against. Shome mishtake!

At last, some good news for $REGN CD20 T-cell engager!

Adcom says: up yours, Prasad

When the FDA says run a randomised trial, run a randomised trial. Via ApexOnco -> oncologypipeline.com/apexonco/node/… $URGN off 45%.

🇨🇳 #3SBio published the Ph2 results of SSGJ-707 #SSGJ707, a bispecific antibody targeting PD-1 and VEGF, as a monotherapy in patients with advanced NSCLC . asco.org/abstracts-pres… Among the 76 pts completed at least one efficacy evaluation, ORR and DCR were 29.6% (8/27)/85.2%

Interesting background to today's Servier menin deal

"No OS detriment", huh? Remember Ascent-04 late-breaker coming at #ASCO25 $GILD $AZN $DSNKY